Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis

Rheumatology

Volumn 48, Issue 3, 2009, Pages 315-316

  Pasquetti, P ^a   Morozzi, G ^a   Galeazzi, M ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; RHEUMATOID FACTOR; STEROID;

ADULT; ANAMNESIS; ANTIBODY TITER; BACKACHE; CLINICAL ASSESSMENT; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; DISEASE DURATION; ENTHESITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOOT RADIOGRAPHY; HAND RADIOGRAPHY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSORIATIC ARTHRITIS; SACROILIITIS; WRIST RADIOGRAPHY;

ADULT; ARTHRITIS, PSORIATIC; AUTOANTIBODIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES, CYCLIC; PROSPECTIVE STUDIES; RHEUMATOID FACTOR;

EID: 61349091221     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ken456     Document Type: Letter

References (10)

1. Taylor W, Gladman D, Helliwell P, Marchesoni A, Meese P, Mielants H; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
2. Vander Cruyssen B, Peene I, Canteen T et al. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relabon with rheumatoid factor. Autoimmun Rev 2005;4:468-74.
3. Inanc, N, Dalkilic E, Kamali S et al. Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis. Clin Rheumatol 2007;26:17-23.
4. Bogliolo L, Alpini C, Caporali R, Scirè CA, Moratti R, Montecucco C. Antibodies to cyclic citrullinated peptides in psoriatic arthritis. J Rheumatol 2005;32:511-5.
5. Alenius GM, Bergin E, Rantapää Dahlqvist S. Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation. Ann Rheum Dis 2006;65:398-400.
6. Vander Cruysseri B, Hoffman IE, Zmierczak H et al, Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005;64:1145-9.
7. Candia L, Marquez J, Gonzalez C et al. Low frequency of anticyclic citrullinated peptide antibodies in psoriatic arthritis but not in cutaneous psoriasis. J Clin Rheumatol 2006;12:226-9.
8. Korendowych E, Owen P, Ravindran J, Carmichael C, McHugh N. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis. Rheumatology 2005;44:1056-60.
9. Helliwell PS, Tailor WJ. Classification and diagnostic criteria for psoriatic arthritis. Ann Rheum Dis 2005;64(Suppl. II):iI3-8.
10. Chen HA, Lin KC, Chen CH et al. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:35-9.